Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2016

Planlagt Fastgjort Låst Flyttet Genmab
2.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #431

    It is amazing to see that we can get MRD negativity in the relapsed space. Both of these combinations were approved in November.

    Noopur Raje, MD
    Massachusetts General Hospital Cancer Center

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #432

      “Daratumumab led to rapid and durable achievement of MRD negativity,” Avet-Loiseau said. “Patients continue to achieve MRD negativity over time. The high rate of MRD negativity may lead to long-term clinical benefit. The magnitude of daratumumab-induced MRD negativity in the relapsed or refractory multiple myeloma setting is unprecedented.” – by Rob Volansky

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #433

        “MRD negativity was consistently higher in patients treated in daratumumab,” Avet-Loiseau said, adding that patients treated with the drug reached MRD negativity as soon as 3 months. “We still see patients achieving MRD negativity.”

        High-risk patients also achieved MRD negative status in both studies, according to Avet-Loiseau. Eighteen percent of high-risk patients in the POLLUX study and 14% of those in CASTOR achieved MRD negativity.

        “The most important factor in achieving PFS is MRD negati

        1 Reply Last reply
        0
        • J Offline
          J Offline
          jkj
          wrote on sidst redigeret af
          #434

          læs også kommenterne i bundenhttp://www.healio.com/hematology-oncology/myeloma/news/online/%7Bd994f56d-5da5-4306-b227-4e31e82ec3d6%7D/daratumumab-associated-with-deep-clinical-response-in-relapsed-refractory-multiple-myeloma

          1 Reply Last reply
          0
          • J Offline
            J Offline
            jkj
            wrote on sidst redigeret af
            #435

            The magnitude of daratumumab-induced MRD negativity in the relapsed or refractory multiple myeloma setting is unprecedented.” – by Rob Volansky

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #436

              "unprecedented".

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #437

                Winkel lovede os flotte data på MRD negativitet på ASH. Det har vi så sandelig fået nu. 😄

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #438

                  Det må man sige. 😄

                  1 Reply Last reply
                  0
                  • T Offline
                    T Offline
                    Thetreble
                    wrote on sidst redigeret af
                    #439

                    Hvad betyder mrd negative ?

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #440

                      Minimal tilbageværende sygdom.

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #441

                        Altså at patienten testes negativt for det.

                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          Thetreble
                          wrote on sidst redigeret af
                          #442

                          Vildt med 80% i pollux

                          1 Reply Last reply
                          0
                          • T Offline
                            T Offline
                            Thetreble
                            wrote on sidst redigeret af
                            #443

                            Men over hvor lang

                            1 Reply Last reply
                            0
                            • T Offline
                              T Offline
                              Thetreble
                              wrote on sidst redigeret af
                              #444

                              .. tid virker det ? Er man kommet det nærmere eller stadigvæk ca. 2 år i gns ?

                              1 Reply Last reply
                              0
                              • T Offline
                                T Offline
                                Thetreble
                                wrote on sidst redigeret af
                                #445

                                Link Preview Image
                                Siden findes ikke

                                favicon

                                (borsen.dk)

                                1 Reply Last reply
                                0
                                • T Offline
                                  T Offline
                                  Thetreble
                                  wrote on sidst redigeret af
                                  #446

                                  Ville være dejligt med nogle flere børsnoteringer i DK og gerne biotek

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    mobbyduck1
                                    wrote on sidst redigeret af
                                    #447

                                    Det ligner et kæmpe nej i Italien, det kan godt give kraftige døninger i morgen! Desværre!

                                    1 Reply Last reply
                                    0
                                    • JonSnowJ Offline
                                      JonSnowJ Offline
                                      JonSnow
                                      wrote on sidst redigeret af
                                      #448

                                      Er det nye og positivt overraskende data, der er blevet præsenteret til ASH?

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        Jedi
                                        wrote on sidst redigeret af
                                        #449

                                        Læs lige interview med Plesner igen - link fra Farfar1952 3/12 http://haematologisktidsskrift.dk/sygdomme/myeloma/222-daratumumab-rundt-pa-365-dage.html?user=al9hjgTY&passw=$2y$10$yNq10FjK8pizHgW/RWm.9O5hsjudYVck2.3tpOkerbTe4.Q8m7ecq

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          Jedi
                                          wrote on sidst redigeret af
                                          #450

                                          I tredie afsnit med overskriften "Bliver førstevalg til alle med myelomatose" udtaler Plesner at inklusion af patienter i et frontline forsøg netop er afsluttet - det må betyde at Maia studiet nu er fuldt rekrutteret, det har vi da ikke hørt før

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger